Regulus Therapeutics reported $625K in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Alnylam Pharmaceuticals ALNY:US $ 54.92M 18.51M
Biogen BIIB:US $ 398.7M 190.5M
Celldex Therapeutics CLDX:US $ 1.02M 0.21M
Gilead Sciences GILD:US $ 583M 122M
Intercept Pharmaceuticals ICPT:US $ 10.39M 7.75M
Intrexon XON:US $ 4.42M 0.99M
Lexicon Pharmaceuticals LXRX:US 9.32M 169K
Ligand Pharmaceuticals LGND:US $ 6.97M 1.43M
Merk MRK:US $ 3715M 894M
Omeros OMER:US $ 7.34M 6.06M
Regulus Therapeutics RGLS:US $ 0.62M 0.34M
Sangamo Biosciences SGMO:US 11.15M 1.39M
Spectrum Pharmaceuticals SPPI:US $ 25.3M 8.1M
Takeda 4502:JP Y 516297M 165112M
Vital Therapies VTL:US $ 3.29M 0.46M
YTE INCY:US $ 152.55M 19.56M